Drug
Belzutifan
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Hypoxia | 146 | 55.7 | 61.3 | signal |
| 2 | Malignant Neoplasm Progression | 208 | 27.3 | 31.3 | signal |
| 3 | Wound Infection | 19 | 23.3 | 23.6 | signal |
| 4 | Anaemia | 283 | 19.8 | 23.9 | signal |
| 5 | Hospice Care | 14 | 19.0 | 19.1 | signal |
| 6 | Therapy Partial Responder | 18 | 15.9 | 16.1 | signal |
| 7 | Oxygen Saturation Decreased | 47 | 11.2 | 11.6 | signal |
| 8 | Therapy Change | 7 | 9.7 | 9.7 | signal |
| 9 | Therapy Interrupted | 47 | 9.1 | 9.3 | signal |
| 10 | Transfusion | 7 | 8.9 | 8.9 | signal |
| 11 | Pneumonitis | 17 | 8.4 | 8.5 | signal |
| 12 | Haemoglobin Decreased | 59 | 7.6 | 7.9 | signal |
| 13 | Myocarditis | 6 | 7.1 | 7.1 | signal |
| 14 | Cholecystitis | 6 | 6.7 | 6.8 | signal |
| 15 | Metastases To Bone | 8 | 6.5 | 6.5 | signal |
| 16 | Proteinuria | 9 | 6.4 | 6.4 | signal |
| 17 | Scratch | 4 | 5.2 | 5.2 | signal |
| 18 | Full Blood Count Abnormal | 4 | 5.1 | 5.1 | signal |
| 19 | Blood Thyroid Stimulating Hormone Increased | 3 | 4.3 | 4.3 | signal |
| 20 | Posterior Reversible Encephalopathy Syndrome | 3 | 4.2 | 4.2 | signal |
| 21 | Inability To Afford Medication | 3 | 4.1 | 4.1 | signal |
| 22 | Palmar-plantar Erythrodysaesthesia Syndrome | 7 | 4.0 | 4.0 | signal |
| 23 | Dialysis | 4 | 3.7 | 3.8 | signal |
| 24 | Haemorrhage Intracranial | 4 | 3.6 | 3.6 | signal |
| 25 | Metastases To Lung | 3 | 3.5 | 3.5 | no signal |
| 26 | Metastases To Central Nervous System | 3 | 3.1 | 3.1 | no signal |
| 27 | Renal Cancer | 7 | 1.9 | 1.9 | no signal |
| 28 | Drug Effective For Unapproved Indication | 4 | 1.8 | 1.8 | no signal |